/FOR DISSEMINATION IN CANADA AND OVER CANADIAN NEWS SERVICES ONLY. THE DISSEMINATION OF THIS RELEASE IN THE UNITED STATES OR TO ANY UNITED STATES NEWS SERVICE MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./
TORONTO, Feb. 1, 2019 /CNW/ - Corriente Master Fund II, LP ("Corriente") announced that it, directly or indirectly, currently owns or controls an aggregate amount of 1,229,400 common shares and 1,129,400 warrants in the capital of DionyMed Brands Inc. (the "Corporation"). This ownership, assuming exercise of the warrants, would represent approximately 11.89% of the total outstanding common shares and 4.37% of the voting interest in the Corporation.
Corriente and its related parties purchased common shares and warrants in connection with the Corporation's previously announced business combination which was completed on November 27, 2018 and following completion of the business combination, Corriente acquired additional common shares through the facilities of the Canadian Securities Exchange (the "CSE"). Corriente was advised by the Corporation on January 31, 2019 that the total number of common shares outstanding is 18,701,167 common shares and that the common shares are a separate class from the proportionate voting shares of the Corporation. The total common shares for ownership purposes is 19,839,567 assuming exercise of the warrants held by Corriente.
Corriente Advisors, LLC is the investment manager of Corriente. Corriente acquired the common shares and warrants for investment purposes, and may acquire further common shares or dispose of its holdings, as investment conditions warrant. The Issuer is listed on the CSE under the symbol "DYME".
SOURCE Corriente Master Fund II, LP
For further information: Matthew Gilman at (817) 870-0404.